Document Detail


Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
MedLine Citation:
PMID:  21699387     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Abstract We report our experience on rituximab-cyclophosphamide-dexamethasone (RCD) combination therapy for the treatment of autoimmune disorders in 48 patients with chronic lymphocytic leukemia (CLL). The diagnosis of autoimmune disease (AID) was autoimmune hemolytic anemia (AIHA) in 26 (54%), autoimmune thrombocytopenic purpura (AITP) in nine (18.8%), Evans syndrome in eight (16.7%), and pure red cell anemia (PRCA) in five patients (10.5%). CLL was considered progressive in 40% of subjects upon AID diagnosis. Overall, an 89.5% response rate was obtained with this combination, irrespective of the AID type. Relapse occurred in 19 patients (39.6%). The median duration of autoimmunity was 24 months, but the duration of response of autoimmunity (DR-AI) was higher for patients presenting with: (1) AID early during the CLL course (<3 years), or (2) both and pure red cell aplasia (PRCA) in five patients (10.5%) and AIHA.
Authors:
Anne-Sophie Michallet; Julien Rossignol; Bruno Cazin; Loic Ysebaert
Related Documents :
21804017 - Aid binds cooperatively with ung and msh2-msh6 to ig switch regions dependent upon the ...
16087847 - Prevalence and burden of self-reported blindness, low vision, and visual impairment in ...
11360447 - The biotoxicity and color formation results from ozonation of wastewaters containing ph...
2606597 - The classic and the romantic vision in psychoanalysis.
15738327 - The concentration of substance use, criminal justice involvement, and hiv/aids in the f...
3317877 - Aids as a social phenomenon.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  52     ISSN:  1029-2403     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-06-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  England    
Other Details:
Languages:  eng     Pagination:  1401-3     Citation Subset:  IM    
Affiliation:
Hospices Civils de Lyon, Department of Hematology, Lyon-Sud University Hospital, Pierre-Bénite, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunoglobulin class switch recombination in chronic lymphocytic leukemia.
Next Document:  Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic ...